Quick Answer
NOVAVAX INC reported Total Revenue of $1.12 billion for the year ending 2025.
- NOVAVAX INC showed an increase of +64.7% in Total Revenue from 2024 to 2025.
- This data is from NOVAVAX INC's annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2013: $4.80 million | Q4 2013: $8.75 million | Q1 2014: $7.46 million | Q2 2014: $8.26 million | Q3 2014: $8.21 million | Q4 2014: $6.72 million | Q1 2015: $9.88 million | Q2 2015: $14.00 million | Q3 2015: $6.53 million | Q4 2015: $5.85 million | Q1 2016: $4.22 million | Q2 2016: $2.51 million | Q3 2016: $3.23 million | Q4 2016: $5.40 million | Q1 2017: $5.68 million | Q2 2017: $6.73 million | Q3 2017: $8.35 million | Q4 2017: $10.41 million | Q1 2018: $9.65 million | Q2 2018: $10.77 million | Q3 2018: $7.74 million | Q4 2018: $6.13 million | Q1 2019: $3.98 million | Q2 2019: $3.36 million | Q3 2019: $2.51 million | Q4 2019: $8.82 million | Q1 2020: $3.38 million | Q2 2020: $35.54 million | Q3 2020: $157.02 million | Q1 2021: $447.23 million | Q2 2021: $298.02 million | Q3 2021: $178.84 million | Q1 2022: $703.97 million | Q2 2022: $185.93 million | Q3 2022: $734.58 million | Q1 2023: $80.95 million | Q2 2023: $424.43 million | Q3 2023: $186.99 million | Q1 2024: $93.86 million | Q2 2024: $415.48 million | Q3 2024: $84.51 million | Q1 2025: $666.66 million | Q2 2025: $239.24 million | Q3 2025: $70.45 million.
- Over the full 16 years of available data (2010 to 2025), NOVAVAX INC's Total Revenue has grown by 327,444.9%.
- Historical annual values: Fiscal year 2025: $1.12 billion | Fiscal year 2024: $682.16 million | Fiscal year 2023: $983.71 million | Fiscal year 2022: $1.98 billion | Fiscal year 2021: $1.15 billion | Fiscal year 2020: $475.60 million | Fiscal year 2019: $18.66 million | Fiscal year 2018: $34.29 million | Fiscal year 2017: $31.18 million | Fiscal year 2016: $15.35 million | Fiscal year 2015: $36.25 million | Fiscal year 2014: $30.66 million | Fiscal year 2013: $20.92 million | Fiscal year 2012: $22.08 million | Fiscal year 2011: $14.69 million | Fiscal year 2010: $343.0 thousand.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: